BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Treatment
13 results:

  • 1. Molecular analysis directs the prognosis, management and treatment of patients with xeroderma pigmentosum.
    Lehmann AR; Fassihi H
    DNA Repair (Amst); 2020 Sep; 93():102907. PubMed ID: 33087273
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
    Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
    J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Human in vitro skin organ culture as a model system for evaluating DNA repair.
    Liu H; Tuchinda P; Fishelevich R; Harberts E; Gaspari AA
    J Dermatol Sci; 2014 Jun; 74(3):236-41. PubMed ID: 24636351
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The toxicity of nitrofuran compounds on melanoma and neuroblastoma cells is enhanced by Olaparib and ameliorated by melanin pigment.
    McNeil EM; Ritchie AM; Melton DW
    DNA Repair (Amst); 2013 Nov; 12(11):1000-6. PubMed ID: 24070777
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. xpf protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: suitability as a biomarker for patient selection.
    Hatch SB; Swift LP; Caporali S; Carter R; Hill EJ; MacGregor TP; D'Atri S; Middleton MR; McHugh PJ; Sharma RA
    Int J Cancer; 2014 Mar; 134(6):1495-503. PubMed ID: 23982883
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
    Li W; Melton DW
    Oncogene; 2012 May; 31(19):2412-22. PubMed ID: 21996734
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Efficient DNA interstrand crosslinking by 6-thioguanine and UVA radiation.
    Brem R; Daehn I; Karran P
    DNA Repair (Amst); 2011 Aug; 10(8):869-76. PubMed ID: 21723207
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Multiple roles of the ERCC1-xpf endonuclease in DNA repair and resistance to anticancer drugs.
    Kirschner K; Melton DW
    Anticancer Res; 2010 Sep; 30(9):3223-32. PubMed ID: 20944091
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Psoralen-induced DNA interstrand cross-links block transcription and induce p53 in an ataxia-telangiectasia and rad3-related-dependent manner.
    Derheimer FA; Hicks JK; Paulsen MT; Canman CE; Ljungman M
    Mol Pharmacol; 2009 Mar; 75(3):599-607. PubMed ID: 19064630
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dermatological high-dose-rate brachytherapy for the treatment of basal and squamous cell carcinoma.
    Sedda AF; Rossi G; Cipriani C; Carrozzo AM; Donati P
    Clin Exp Dermatol; 2008 Nov; 33(6):745-9. PubMed ID: 18681873
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chemosensitivity of primary human fibroblasts with defective unhooking of DNA interstrand cross-links.
    Clingen PH; Arlett CF; Hartley JA; Parris CN
    Exp Cell Res; 2007 Feb; 313(4):753-60. PubMed ID: 17188678
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Assessment of organ radiation dose associated with uterine artery embolization.
    Glomset O; Hellesnes J; Heimland N; Hafsahl G; Smith HJ
    Acta Radiol; 2006 Mar; 47(2):179-85. PubMed ID: 16604965
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Sarcoidosis of the breast: implications for the general surgeon.
    Ojeda H; Sardi A; Totoonchie A
    Am Surg; 2000 Dec; 66(12):1144-8. PubMed ID: 11149586
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.